Page last updated: 2024-08-23

silybin and Bone Cancer

silybin has been researched along with Bone Cancer in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheung, KSC; Leung, F; Liu, ZL; Lu, WW; Sun, T1
Anders, I; Bauer, R; Deutsch, A; Durchschein, C; Jahanafrooz, Z; Kleinegger, F; Kretschmer, N; Lohberger, B; Rinner, B; Stallinger, A1
Chen, PN; Chu, SC; Hsieh, YS; Liu, YC; Lu, KH; Yang, SF1

Other Studies

3 other study(ies) available for silybin and Bone Cancer

ArticleYear
Matrix metallopeptidase 9 targeted by hsa-miR-494 promotes silybin-inhibited osteosarcoma.
    Molecular carcinogenesis, 2018, Volume: 57, Issue:2

    Topics: Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Core Binding Factor Alpha 1 Subunit; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 9; MicroRNAs; Osteosarcoma; Silybin; Silymarin; Up-Regulation

2018
Influence of silibinin and β-β-dimethylacrylshikonin on chordoma cells.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2018, Oct-01, Volume: 49

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Bone Neoplasms; Boraginaceae; Caspase 3; Cell Line, Tumor; Cell Survival; Chordoma; Humans; Mitochondria; Naphthoquinones; Plant Roots; Signal Transduction; Silybin; Silymarin

2018
Silibinin suppresses human osteosarcoma MG-63 cell invasion by inhibiting the ERK-dependent c-Jun/AP-1 induction of MMP-2.
    Carcinogenesis, 2007, Volume: 28, Issue:5

    Topics: Bone Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Shape; Cell Survival; Disease Progression; Extracellular Signal-Regulated MAP Kinases; Focal Adhesion Kinase 1; Humans; Male; Matrix Metalloproteinase 2; Neoplasm Invasiveness; Osteosarcoma; Proto-Oncogene Proteins c-jun; Signal Transduction; Silybin; Silymarin; Transcription Factor AP-1; Urokinase-Type Plasminogen Activator

2007